| Tag | Content |
|---|
EnhancerAtlas ID | HS162-00472 |
Organism | Homo sapiens |
Tissue/cell | Plasma_cell_myeloma |
Coordinate | chr1:120751430-120754040 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxd3 | MA0041.1 | chr1:120754021-120754033 | AAACAAACAAAC | - | 6.32 | | Gata1 | MA0035.3 | chr1:120752545-120752556 | TCCTTATCTCT | + | 6.02 | | IRF1 | MA0050.2 | chr1:120753612-120753633 | CAGCTCTTTCACTTTCATTTC | + | 7.2 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09381 | chr1:120746967-120763810 | CD14 | | SE_36823 | chr1:120752543-120754600 | HMEC |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | AGGCATGACC CACCGTGCCC GACTTATATA CATTTCTGAT AATACATAAA ATCTATCCCA 60
TAGGTTCTTT GATCCTTTAA CTTTTCGATA AAGAAGGTAC AGAAAGTGAT AGGAATTGAA 120
CAAAACTAGT GGCTTCAAAC TTTGGCAATC CAACACACAT GCACACACAC ATACACACAC 180
AACTGAAAAG TGTCATGAAA CAACATTTAT CCTTAGTCAT GAACTCTGAT ATTTTCTATA 240
ACTTTTTAAA TGCTGGTTGT GGCTCACTAA TTTGCTTTCA TGATTTAGTA AAAGGTCTCA 300
ACCTGCAGTT TGAAAAGCTG TGGAATAAAC CACATGGCCA CCAAAGGCAG AACTAGAACA 360
GTCTTCAAAC CACTCAGCTC CTTCTTCATG GGCTATTATT AAATCAGAAA GGGCCTAAGT 420
TTCACTTATT GCTGTAAAAG AAACTGTACA TTCCGTATCC TCCTCCTTTG CCCTCCACAG 480
TTCACGTGAG CACTAGAAAT TCAGAGAACA CCCAGGAACC AGTGGGCACT TCCTATGTAT 540
GCAACTCATG TTACTGTTGC CCAATCTAAG GTGCTGCCAT TCAACATCAG GGAGAGTCCT 600
GTGGCCTGTT CTCTTAGTTT CGTCTTCCTT ATTTTGAGGC CCAGCAACCG TCATCATTCA 660
CTGTACCTTT GGAGCAAAGA AGTTGCTGAT CTAAACACCA CAAGGCAATG TTGTTATATA 720
TTTAGTAAAA AGATTATAAA CAGACTAGAT GAAACTTATT AGTGGTTAAG TTTAAAAAAA 780
CAAAACAAAA CACCAAAAAA AAAAACAGTC CAGCTGGGCG CGGTGGCTCA CGCCTATAAT 840
CCCAGCACTT TGGGAGGCCA ATGCAGGCAG ACCACGAGGT CAGGAGATCG AGACCATCCT 900
GGCTAACACA GTGAAACCCC GTCTCTACTA AAAAAAAATA CAAAAAAAGT AGCTGGGCGT 960
GGTGGCGGGC GCCTGTAGTC CCAGCTACTC AGGAGGCTGA GGCAGGAGAA TGGCGTGAAC 1020
CCGGGAGGCG GAGCTTGCAG TGAGCTGAGA TGGCACCACT GCACTCCAGC CTGGGCGACA 1080
GAGCGAGACT CCGTCTCAAA AAAAAAAAAA AAACCTCCTT ATCTCTTAAA TATTGAAATA 1140
TTCAAAGATA AATTATATCT GCTATTGTTT CAAAGTAATG GAGGAGAGTG GGAATGGGTG 1200
AGGGATACAG ATAAAACAAA ATTGGCCCTG AGCTGATGAT TATCAAAGTA GCATGATGGG 1260
TACATGAGAA TCCATAACAC TAGTCTCTCT ACTGTATATA TTTGAAATTT TTTATAATAA 1320
AAAGTTTTTA AATATCTAAT TAATGGTGTG TAAAAAAAAG GCTTAAGAGA CTCACAATAA 1380
ATGCAGAGGA AGACAATAAA TAAAACAGAA AAAAATATCC AGAGAACTAA ATCTGTGAAT 1440
AGAAAAGGCC CATAATATAT CATGAAATGA ACACAGAAAA ATCAACAAAG ACTTATAATG 1500
TTTAAATTTT TGCCCTTCAA GGATAAAGAA AGAGTTATTT AAGAATCAAT GGATTGCTAA 1560
CAAAATACAG CAGAAACCCA GATTGGTCTC AGACTTCTCC ACAGCAATAT TCAAGGCCTG 1620
AAGATAAAGT AGCCATGTCT TAAAAAATTC TGATAGAGAG CAACTGTGAT CCAAGAATAT 1680
TAGGAGAAGC TGAGTCATCA CTCAAGTGTA AAAAAGGTTC AGACATCTCT CTTCCTCTGC 1740
AACTTGAAAG ATCTCAGCCT ATGTAGCACC CACGAACTCG TCTTGAGAAA CAGAAATCTT 1800
GCACCCAGTA GATCAATCAA AACAAAAACC ACAGGAACAG GAAAGCCACG ATCAAAGAAC 1860
AAGTGGCTAC ATATGGCACC AAGACCAAAA AATGGGAGCA TGCAAGTTGG AATGTAAATG 1920
TTAGAAAATT GCCAAGGCAA AAAAAGAAAC AACAAAAAAA AGATAAGCTA TAAAAATTGA 1980
GAGATAGGAA GAGTAGTGCA AGGAAGTTTA AAAACACGAA TTACCTAATT CTTCCAGACA 2040
ATCATCTAAA GTGAAGATAT AACTAAAAAT GTCTTTAAAA ATATTAATAG TGACTTTAGC 2100
CTCCTAACAG TTTTCATAAT CTTTTTTTAA CCTTAGAGAA AACTTTTAGG AACTATTATC 2160
TTTGGTAGAG AAAAAAGTAC AGCAGCTCTT TCACTTTCAT TTCAGTTTTC TTTTCTTCTG 2220
TTAAATTCAA GTAAAAAGAA ATGCAGTTAT TTTTATTTTT ATAGTACATA TGGTATAATG 2280
CCATTCTTAT AAAATTATTT CACCCTCACC AGCCACCCTT CTGTTTATGT GTACCAAATG 2340
TTAACACTGG AAGAGAAAGT CCATATGCAC CATTACCAAA TCCAGAGCCT TCCCCTCCTA 2400
CCTGCCTGCC CTGTCTCAGC CTCTAACCTA GGTTTATCTT TCTACCTGCA AACCAGAACC 2460
CACCCCTTCT TGCTTACTCA AGCCCTTTCC TCCTAAAATT ATACACTCTT ATTTTCCGTA 2520
TCATCATTTT CCATCTCTAC TGGCCCATTA CCAGCAGCAG TCAAACACAC TGTATTTTCT 2580
CCCATCTTAT TAAACAAACA AACGCATATT 2610
|
